Alain Wagner

Research Director, Centre National de la Recherche Scientifique (CNRS), Laboratory of Biofunctional Chemistry, UMR7199
University of Strasbourg
Dr. Alain Wagner received a PhD in organic chemistry from Université Louis Pasteur (1991), followed by a post-doctoral fellowship with Prof. Peter Schultz at Affymax Research Institute (1991-1993, Palo Alto, USA). He joined CNRS in 1994 to develop projects dealing with combinatorial approaches in drug discovery. Promoted research director in 2001, Alain Wagner took a sabbatical to found Novalix Pharma (2002-2007). He later participated actively in the creation of eNovalys (2009) a pioneering company that stake on the digital technology exploiting raw experimental data as a source of innovation. On returning to the CNRS (2008) he took the lead of the BioFunctional Chemistry Lab ( to investigate xenobiotic synthetic reactivity for interfering with living organisms. Alain has recently co-founded Syndivia SAS, which provides advanced technologies for drug bio-conjugation / drug release (2014). Dr Wagner published more than 150 articles and is an inventor of 22 patents. He is currently involved in the creation of MicroOmiX Technology a company developing advanced single cell secretomic analytics.


November 7 2019, 14:20
 - 14:50
Droplet Microfluidic-Based Single Cell Secretomic Analysis